3c, e), Glp1r expression was detected at low levels in two neuronal subtypes CA3 neurons expressing Csf2rb2 and caudal ganglionic eminence neurons expressing Htr3a (Supplementary Fig
The effect of tirzepatide on 24-hour mean systolic BP, diastolic BP, and heart rate (HR) measured during 24-hour ambulatory BP monitoring (ABPM) in individuals living with obesity without T2DM, has been evaluated in the SURMOUNT-1 ABPM sub-study.34 After 36 weeks of treatment, tirzepatide was associated with statistically significant and clinically meaningful reductions in the mean 24-hour systolic BP at all doses and reduced diastolic BP at the 2 lower doses.34 Simultaneously, tirzepatide treatment was associated with a dose-dependent increase in the mean 24-hour HR.34 Fortunately, there is no clear evidence that tirzepatide increases the risk of atrial fibrillation.35 5
At this stage, the focus shifts toward maintenance, metabolic health, and overall wellness
And what, how are local doctors and healthcare experts, addiction experts handling these potential unknowns Chris Serres: , I mean, theres a lot of excitement around this